Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: An 11-year retrospective hospital-based study in Japan

Modern Rheumatology

Volumn 20, Issue 1, 2010, Pages 54-62

  Suzuki, Yusuke ^a   Takeda, Yukihiko ^a   Sato, Daisuke ^a   Kanaguchi, Yasuhiko ^a   Tanaka, Yuichi ^a   Kobayashi, Shigeto ^b   Suzuki, Kazuo ^c   Hashimoto, Hiroshi ^b   Ozaki, Shoichi ^d   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Juntendo University Hospital   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Microscopic polyangiitis (MPA); MPO ANCA; PR3 ANCA; Wegener's granulomatosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INCIDENCE; JAPAN; KIDNEY FAILURE; MALE; MICROSCOPIC POLYANGIITIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SEROLOGY; WEGENER GRANULOMATOSIS;

ADMINISTRATION, ORAL; AGE OF ONSET; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; COMORBIDITY; FEMALE; GLOMERULONEPHRITIS; GLUCOCORTICOIDS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; JAPAN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES;

EID: 76649124252     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0239-0     Document Type: Article

References (29)

1. JC Jennette RJ Falk 1997 Small-vessel vasculitis N Engl J Med 337 1512 1523 10.1056/NEJM199711203372106 1:STN:280:DyaK1c%2Fis1Oluw%3D%3D 9366584 (Pubitemid 27495778)
2. G Haugeberg R Bie A Bendvold AS Larsen V Johnsen 1998 Primary vasculitis in a Norwegian community hospital: a retrospective study Clin Rheumatol 17 364 368 10.1007/BF01450893 1:STN:280:DyaK1M%2FitF2qtw%3D%3D 9805179 (Pubitemid 28483133)
3. RA Watts SE Lane G Bentham DG Scott 2000 Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom Arthritis Rheum 43 414 419 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0 1:STN:280:DC%2BD3c7lsFGmsg%3D%3D 10693883 (Pubitemid 30395752)
4. RA Watts DG Scott DRW Jayne T Ito-Ihara E Muso S Fujimoto, et al. 2008 Renal vasculitis in Japan and UK-are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant. 43 12 3743 3745
5. SE Lane DG Scott A Heaton RA Watts 2000 Primary renal vasculitis in Norfolk-increasing incidence or increasing recognition? Nephrol Dial Transplant 15 23 27 10.1093/ndt/15.1.23 1:STN:280:DC%2BD3c%2Fns1KisQ%3D%3D 10607763
6. E Reinhold-Keller K Herlyn R Wagner-Bastmeyer WL Gross 2005 Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register Arthritis Rheum 53 93 99 10.1002/art.20928 15696553 (Pubitemid 40216357)
7. S Fujimoto S Uezono S Hisanaga K Fukudome S Kobayashi K Suzuki, et al. 2006 Incidence of ANCA-associated primary renal vasculitis in Miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan Clin J Am Soc Nephrol 1 1016 1022 10.2215/CJN.01461005 17699321
8. Matsumoto Y, Inaba Y, Nakayama T, et al. Nationwide epidemiological survey of refractory vasculitis (anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, anti-phospholipid syndrome and temporal arteritis) in Japan. Annual report of the research committee on intractable vasculitides, Ministry of Health and Welfare of Japan [in Japanese], Tokyo. 1998. p. 15-23.
9. H Sakai K Kurokawa A Koyama Y Arimura H Kida H Shigematsu, et al. 2002 Committee for the Guidelines on Diagnosis and Therapy of Rapidly Progressive Glomerulonephritis: guidelines for the management of rapidly progressive glomerulonephritis [in Japanese] Jpn J Nephrol 44 55 82
10. K Yamagata K Hirayama K Mase N Yamaguchi M Kobayashi H Takahashi, et al. 2005 Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: Lessons learned from Japan Nationwide survey of RPGN J Clin Apheresis 20 244 251 10.1002/jca.20035 15880406
11. Koyama A, Yamagata K, Makino H, Ariyama Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009 (Epub ahead of pub).
12. MA Gonzalez-Gay C Garcia-Porrua J Guerrero P Rodriguez-Ledo J Llorca 2003 The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions Arthritis Rheum 49 388 393 10.1002/art.11115 12794795
13. AD Booth MK Almond A Burns P Ellis G Gaskin GH Neild, et al. 2003 Pan-Thames Renal Research Group: outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Am J Kidney Dis 41 776 784 10.1016/S0272-6386(03) 00025-8 12666064
14. JC Jennette H Xiao RJ Falk 2006 Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies J Am Soc Nephrol 17 1235 1242 10.1681/ASN.2005101048 16624929 (Pubitemid 43673403)
15. CG Kallenberg P Heeringa CA Stegeman 2006 Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides Nat Clin Pract Rheumatol 2 661 670 10.1038/ncprheum0355 1:CAS:528:DC%2BD28XhtlentL3I 17133251 (Pubitemid 44830855)
16. MD Morgan L Harper J Williams C Savage 2006 Anti-neutrophil cytoplasm-associated glomerulonephritis J Am Soc Nephrol 17 1224 1234 10.1681/ASN.2005080882 1:CAS:528:DC%2BD28XkvVKrsr8%3D 16624931 (Pubitemid 43673402)
17. P van Paassen JW Cohen Tervaert P Heeringa 2007 Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis? Nephron Exp Nephrol 105 e10 e16 10.1159/000096960 17108705 (Pubitemid 46006572)
18. SC Satchell AJ Nicholls RJ D'Souza M Beaman 2004 Renal vasculitis: increasingly a disease of the elderly? Nephron Clin Pract 97 c142 c146 10.1159/000079173 1:STN:280:DC%2BD2cvis1Cgug%3D%3D 15331937 (Pubitemid 39179247)
19. JB Levy CG Winearls 1994 Rapidly progressive glomerulonephritis: what should be first-line therapy? Nephron 67 402 407 10.1159/000188012 1:STN:280:DyaK2M%2FlvFKmtQ%3D%3D 7969671
20. M Haas BH Spargo EJ Wit MJ Meehan 2000 Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases Am J Kidney Dis 35 433 447 10.1016/S0272-6386(00)70196-X 1:STN:280: DC%2BD3c7mtVCitA%3D%3D 10692269
21. HA Hauer IM Bajema HC van Houwelingen F Ferrario LH Noel R Waldherr, et al. 2002 European Vasculitis Study Group (EUVAS). Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups Kidney Int 61 80 89 10.1046/j.1523-1755.2002.00089.x 11786087 (Pubitemid 34075133)
22. N Tsuchiya S Kobayashi A Kawasaki C Kyogoku Y Arimura M Yoshida, et al. 2003 Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis J Rheumatol 30 1534 1540 1:CAS:528:DC%2BD3sXmtFSqsLg%3D 12858454
23. M Yashiro E Muso T Itoh-Ihara A Oyama K Hashimoto T Kawamura, et al. 2000 Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan) Am J Kidney Dis 35 889 895 10.1016/S0272-6386(00)70260-5 1:STN:280:DC%2BD3c3lsFWiug%3D%3D 10793024
24. T Ito-Ihara E Muso S Kobayashi K Uno N Tamura Y Yamashita, et al. 2008 A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe Clin Exp Rheumatol 26 1027 1033 1:STN:280:DC%2BD1M7jsFCkug%3D%3D 19210866
25. WG Couser 1998 Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy Am J Kidney Dis 11 449 464
26. R Angangco S Thiru VL Esnault AK Short CM Lockwood DB Oliveira 1994 Does truly 'idiopathic' crescentic glomerulonephritis exist? Nephrol Dial Transplant 9 630 636 1:STN:280:DyaK2M%2FmtVWhtg%3D%3D 7970088
27. JC Jennette 2003 Rapidly progressive crescentic glomerulonephritis Kidney Int 63 1164 1177 10.1046/j.1523-1755.2003.00843.x 12631105 (Pubitemid 36315601)
28. D Jayne N Rasmussen K Andrassy C Bacon JW Tervaert D Dadoniene, et al. 2003 A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 36 44 10.1056/NEJMoa020286 1:CAS:528:DC%2BD3sXltFGku70%3D 12840090 (Pubitemid 36765101)
29. DR Jayne G Gaskin N Rasmussen D Abramowicz F Ferrario L Guillevin, et al. 2007 European Vasculitis Study Group: randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180 2188 10.1681/ASN.2007010090 1:CAS:528: DC%2BD2sXotlWnur0%3D 17582159 (Pubitemid 47041083)